Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperthermophilic Bacteria01:21

Hyperthermophilic Bacteria

Domain Bacteria includes some unique hyperthermophilic species. They exhibit remarkable adaptations that enable survival in extreme environments.Thermotoga species are rod-shaped, gram-negative, non-sporulating hyperthermophiles that form a sheath-like envelope called a toga. They ferment sugars or starch, producing lactate, acetate, CO₂, and H₂, and can also grow via anaerobic respiration using H₂ and ferric iron. Found in hot springs and hydrothermal vents, over 20% of their genes show strong...
Upstream Processing01:27

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regulation of wakefulness by astrocytes in the lateral hypothalamus.

Neuropharmacology·2022
Same author

Linear ubiquitination of PTEN impairs its function to promote prostate cancer progression.

Oncogene·2022
Same author

TGFB2-AS1 inhibits triple-negative breast cancer progression via interaction with SMARCA4 and regulating its targets <i>TGFB2</i> and <i>SOX2</i>.

Proceedings of the National Academy of Sciences of the United States of America·2022
Same author

Baseline proteomics characterisation of the emerging host biomanufacturing organism Halomonas bluephagenesis.

Scientific data·2022
Same author

Dose-response relationship between dietary inflammatory index and diabetic kidney disease in US adults.

Public health nutrition·2022
Same author

Enhanced bone regeneration <i>via</i> PHA scaffolds coated with polydopamine-captured BMP2.

Journal of materials chemistry. B·2022

Related Experiment Video

Updated: Jun 25, 2026

Generation of Marked and Markerless Mutants in Model Cyanobacterial Species
11:45

Generation of Marked and Markerless Mutants in Model Cyanobacterial Species

Published on: May 29, 2016

12.1K

Ectoine hyperproduction by engineered Halomonas bluephagenesis.

Qitiao Hu1, Simian Sun2, Zhongnan Zhang2

  • 1School of Life Sciences, Tsinghua University, Beijing, 100084, China; Manchester Institute of Biotechnology, Department of Chemistry, The University of Manchester, Manchester, M1 7DN, UK.

Metabolic Engineering
|February 24, 2024
PubMed
Summary
This summary is machine-generated.

Engineered Halomonas bluephagenesis now produces high-yield ectoine (85 g/L) using an unsterile fermentation process. This breakthrough advances the industrial biotechnology of ectoine and other valuable compounds.

Keywords:
EctoineHalomonasMetabolic engineeringNGIBNext generation industrial biotechnologyPHASynthetic biology

More Related Videos

Genetic Modification of Cyanobacteria by Conjugation Using the CyanoGate Modular Cloning Toolkit
08:25

Genetic Modification of Cyanobacteria by Conjugation Using the CyanoGate Modular Cloning Toolkit

Published on: October 31, 2019

16.1K
Natural Transformation, Protein Expression, and Cryoconservation of the Filamentous Cyanobacterium Phormidium lacuna
11:47

Natural Transformation, Protein Expression, and Cryoconservation of the Filamentous Cyanobacterium Phormidium lacuna

Published on: February 1, 2022

2.7K

Related Experiment Videos

Last Updated: Jun 25, 2026

Generation of Marked and Markerless Mutants in Model Cyanobacterial Species
11:45

Generation of Marked and Markerless Mutants in Model Cyanobacterial Species

Published on: May 29, 2016

12.1K
Genetic Modification of Cyanobacteria by Conjugation Using the CyanoGate Modular Cloning Toolkit
08:25

Genetic Modification of Cyanobacteria by Conjugation Using the CyanoGate Modular Cloning Toolkit

Published on: October 31, 2019

16.1K
Natural Transformation, Protein Expression, and Cryoconservation of the Filamentous Cyanobacterium Phormidium lacuna
11:47

Natural Transformation, Protein Expression, and Cryoconservation of the Filamentous Cyanobacterium Phormidium lacuna

Published on: February 1, 2022

2.7K

Area of Science:

  • Biotechnology
  • Microbial Engineering
  • Biochemical Production

Background:

  • Ectoine is a valuable osmoprotectant with applications in cosmetics and medicine.
  • Current ectoine production methods face challenges with stringent fermentation and low yields.

Purpose of the Study:

  • To engineer the native ectoine producer Halomonas bluephagenesis for enhanced ectoine production.
  • To develop a cost-effective and scalable biomanufacturing process for ectoine.

Main Methods:

  • Systematic genetic engineering of H. bluephagenesis, including ectABC operon overexpression and precursor availability enhancement.
  • Optimization of the fermentation process, including growth medium and transport system.
  • Demonstration of decoupling salt concentration and co-production with bioplastics.

Main Results:

  • Achieved a high ectoine titer of 85 g/L in 52 hours.
  • Successfully implemented an open, unsterile fermentation process in a 7L bioreactor.
  • Demonstrated feasibility of decoupling salt concentration and co-producing ectoine with P(3HB-co-4HB).

Conclusions:

  • Engineered H. bluephagenesis is a promising chassis for Next-Generation Industrial Biotechnology (NGIB).
  • The developed process significantly increases ectoine yield and reduces production complexity.
  • This work paves the way for efficient biomanufacturing of ectoine and other small molecules.